CH EPL (R5)
1.0.1 - trial-use Switzerland flag

CH EPL (R5), published by Federal Office of Public Health FOPH. This guide is not an authorized publication; it is the continuous build for version 1.0.1 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/bag-epl/bag-epl-fhir/ and changes regularly. See the Directory of published versions

Table of Contents

.. 0 Table of Contents
... 1 Home
... 2 FOPH ePL
... 3 FHIR Standard HL7
... 4 ISO IDMP Standard (ISO 11615)
... 5 IDMP and FHIR
... 6 Swiss IDMP Implementation
... 7 EMA IDMP Implementation and SPOR Overview
... 8 Swissmedic IDMP Implementation
... 9 Dataexport FOPH Specialities List
... 10 Abrilada
... 11 Cuprior
... 12 Entocort
... 13 Estalis
... 14 Keytruda
... 15 Paxlovid
... 16 Triogen
... 17 Profiles
... 18 Extensions
... 19 Terminology
... 20 Changelog
... 21 Artifacts Summary
.... 21.1 AdministrableProductDefinition
.... 21.2 Bundle
.... 21.3 ClinicalUseDefinition Indication
.... 21.4 DocumentReference
.... 21.5 Ingredient
.... 21.6 ManufacturedItemDefinition
.... 21.7 MedicinalProductDefinition
.... 21.8 Organization
.... 21.9 PackagedProductDefinition
.... 21.10 RegulatedAuthorization
.... 21.11 EMA LOC Identifier
.... 21.12 FOPH Dossier Number
.... 21.13 GLN Identifier
.... 21.14 SMC Identifier
.... 21.15 CH EPL - Product Price
.... 21.16 CH EPL - Regulated Authorization Limitation
.... 21.17 CH EPL - Reimbursement SL
.... 21.18 CH SMC - Authorized Dose Form
.... 21.19 CH - Authorisation Type
.... 21.20 CH - Medicinal Product Name Type
.... 21.21 CH - Other Characteristics Type
.... 21.22 CH EPL - Gamme
.... 21.23 CH EPL - Index Therapeuticus
.... 21.24 CH EPL - Limitation Status
.... 21.25 CH EPL - Listing Status
.... 21.26 CH EPL - Other Characteristics Packaged Item
.... 21.27 CH EPL - Price Type
.... 21.28 CH EPL - Product Type
.... 21.29 CH EPL - Reimbursement Status
.... 21.30 CH EPL - Type of Price Change
.... 21.31 CH SMC - Additional Monitoring Indicator
.... 21.32 CH SMC - Attached Document Type
.... 21.33 CH SMC - Authorisation Category
.... 21.34 CH SMC - Authorisation Status
.... 21.35 CH SMC - Authorised Pharmaceutical Dose Form
.... 21.36 CH SMC - Ingredient Role
.... 21.37 CH SMC - Legal Status of Supply
.... 21.38 CH SMC - Marketing Status
.... 21.39 CH SMC - Pediatric Use Indicator
.... 21.40 CH SMC - Special Precautions for Storage
.... 21.41 CH SMC - Substance
.... 21.42 CH SMC - TherapeuticProductcode
.... 21.43 EDQM - Combination Packaging
.... 21.44 EDQM - Combined Pharmaceutical Dose Form
.... 21.45 EDQM - Combined Term
.... 21.46 EDQM - Packaging
.... 21.47 EDQM - Pharmaceutical Dose Form
.... 21.48 EDQM - Route Of Administration
.... 21.49 EDQM - Unit of Presentation
.... 21.50 EMA - Domain
.... 21.51 EMA - Intended Effect
.... 21.52 EMA - Shelf Life Type
.... 21.53 CH - Authorisation Type
.... 21.54 CH - Medicinal Product Name Type
.... 21.55 CH - Other Characteristics Type
.... 21.56 CH EPL - Gamme
.... 21.57 CH EPL - Index Therapeuticus
.... 21.58 CH EPL - Limitation Status
.... 21.59 CH EPL - Listing Status
.... 21.60 CH EPL - Other Characteristics Packaged Item
.... 21.61 CH EPL - Price Type
.... 21.62 CH EPL - Product Type
.... 21.63 CH EPL - Reimbursement Status
.... 21.64 CH EPL - Type of Price Change
.... 21.65 CH SMC - Additional Monitoring Indicator
.... 21.66 CH SMC - Attached Document Type
.... 21.67 CH SMC - Authorisation Category
.... 21.68 CH SMC - Authorisation Status
.... 21.69 CH SMC - Ingredient Role
.... 21.70 CH SMC - Legal Status of Supply
.... 21.71 CH SMC - Marketing Status
.... 21.72 CH SMC - Pediatric Use Indicator
.... 21.73 CH SMC - Special Precautions for Storage
.... 21.74 CH SMC - Substance
.... 21.75 CH SMC - TherapeuticProductcode
.... 21.76 EDQM - Standard Terms
.... 21.77 EMA - Domain
.... 21.78 EMA - Intended Effect
.... 21.79 EMA - Shelf Life Type
.... 21.80 Application / Assessment Tracking Number
.... 21.81 Clinical Product Identifier
.... 21.82 FOPH Dossier Number
.... 21.83 GLN Identifier
.... 21.84 Global Trade Item Number
.... 21.85 LOC Identifier
.... 21.86 Marketing Authorisation Number
.... 21.87 Medical Product Identifier
.... 21.88 Pharmaceutical Product Identifier
.... 21.89 Swissmedic Location Identifier
.... 21.90 5204201
.... 21.91 52042011
.... 21.92 5470402
.... 21.93 54704089
.... 21.94 66231001
.... 21.95 6623101
.... 21.96 67431001
.... 21.97 6743101
.... 21.98 67719001
.... 21.99 6771901
.... 21.100 67831001
.... 21.101 67831001
.... 21.102 6783101
.... 21.103 68793001
.... 21.104 6879301
.... 21.105 ABRILADA Inj Lös 40 mg/0.8ml Fertpen 0.8 ml (Bundle)
.... 21.106 ABRILADA solution for injection 40 mg/0.8 mL pre-filled pen, 1 × 0.8 ml
.... 21.107 ABRILADA solution for injection 40 mg/0.8 mL pre-filled pen, 2 × 0.8 ml
.... 21.108 Abrilada, Injektionslösung
.... 21.109 Abrilada, Injektionslösung Fachinformation
.... 21.110 Abrilada, Injektionslösung Fachinformation
.... 21.111 AXLOVID film-coated tablets 4 × 150 mg / 2 × 100 mg
.... 21.112 CUPRIOR film-coated tablets 150 mg, 72 tablets
.... 21.113 CUPRIOR Filmtabl 150 mg (Bundle)
.... 21.114 CUPRIOR Filmtabl 150 mg 72 Stk
.... 21.115 Cuprior, Filmtabletten Fachinformation
.... 21.116 Cuprior, Filmtabletten Patienteninformation
.... 21.117 ENTOCORT Enema Klistier Lösung + Tabletten 7 Stk
.... 21.118 ENTOCORT Enema Klistier Lösung + Tabletten 7 Stk (Bundle)
.... 21.119 ENTOCORT Enema Klistier Lösung + Tabletten 7 Stk Fachinformation
.... 21.120 ENTOCORT Enema Klistier Lösung + Tabletten 7 Stk Patienteninformation
.... 21.121 ENTOCORT enema, rectal solution + tablets, 7 units
.... 21.122 ESTALIS matrix patch 50/250, 24 units
.... 21.123 ESTALIS Matrixpfl 50/250 24 Stk
.... 21.124 ESTALIS Matrixpfl 50/250 24 Stk (Bundle)
.... 21.125 ESTALIS Matrixpfl 50/250 24 Stk Fachinformation
.... 21.126 ESTALIS Matrixpfl 50/250 24 Stk Patienteninformation
.... 21.127 Indication 10002556
.... 21.128 Indication 10003268
.... 21.129 Indication 10009900
.... 21.130 Indication 10019927
.... 21.131 Indication 10020041
.... 21.132 Indication 10021782
.... 21.133 Indication 10027400
.... 21.134 Indication 10028881
.... 21.135 Indication 10030247
.... 21.136 Indication 10031285
.... 21.137 Indication 10037153
.... 21.138 Indication 10037160
.... 21.139 Indication 10043971
.... 21.140 Indication 10045365
.... 21.141 Indication 10046851
.... 21.142 Indication 10061091
.... 21.143 Indication 10075566
.... 21.144 Indication 10084529
.... 21.145 Indication 10089182
.... 21.146 KEYTRUDA Inf Konz 100 mg / 4 ml
.... 21.147 KEYTRUDA Inf Konz 100 mg / 4 ml (Bundle)
.... 21.148 KEYTRUDA infusion concentrate 100 mg / 4 ml
.... 21.149 Keytruda, Konzentrat zur Herstellung einer Infusionslösung Fachinformation
.... 21.150 Limitation 156370009
.... 21.151 Limitation 20416.XX
.... 21.152 Limitation 254837009
.... 21.153 Limitation 34000006
.... 21.154 Limitation 59393003
.... 21.155 Limitation 64766004
.... 21.156 Limitation 69896004
.... 21.157 Limitation 79886009
.... 21.158 Limitation 79886009
.... 21.159 Limitation 840539006
.... 21.160 Limitation 9014002
.... 21.161 Limitation 90560007
.... 21.162 Limitation 9631008
.... 21.163 MI Abrilada-40mg-Pre-Filled-Pen
.... 21.164 MI Budesonidum-2.3mg-Tablet
.... 21.165 MI Estradiol-hemihydrate-Norethisteroni-acetas-Transdermal-patch
.... 21.166 MI Nirmatrelvir-150mg-Tablet
.... 21.167 MI Pembrolizumab-100mg-Vial
.... 21.168 MI Ritonavirum-100mg-Tablet
.... 21.169 MI Solvent
.... 21.170 MI Trientinum-150mg-Tablet
.... 21.171 MI Trientinum-250mg-Capsule
.... 21.172 PAXLOVID Filmtabl 4x150mg/2x100mg
.... 21.173 PAXLOVID Filmtabl 4x150mg/2x100mg (Bundle)
.... 21.174 Paxlovid, Filmtabletten Patienteninformation
.... 21.175 PhP Abrilada-40mg-Pre-Filled-Pen
.... 21.176 PhP Budesonidum-Suspension
.... 21.177 PhP Estradiol-hemihydrate and Norethisteroni-acetas Transdermal-patch
.... 21.178 PhP Pembrolizumab-100mg-Vial
.... 21.179 PhP Trientinum-150mg-Tablet
.... 21.180 PhP Trientinum-150mg-Tablet
.... 21.181 PhP-Nirmatrelvir-150mg-Filmcoatedtablet
.... 21.182 PhP-Ritonavirum-100mg-Filmcoatedtablet
.... 21.183 Professional Information Paxlovid, Filmtabletten Fachinformation
.... 21.184 Reimbursement SL 17418
.... 21.185 Reimbursement SL 17973
.... 21.186 Reimbursement SL 20416
.... 21.187 Reimbursement SL 21070
.... 21.188 Reimbursement SL 21203 1 Pre-Filled Pen
.... 21.189 Reimbursement SL 21203 2 Pre-Filled Pen
.... 21.190 Reimbursement SL 21208
.... 21.191 Reimbursement SL 21529
.... 21.192 TRIOGEN capsules 250 mg, pack of 100
.... 21.193 TRIOGEN Kaps 250 mg Ds 100 Stk
.... 21.194 TRIOGEN Kaps 250 mg Ds 100 Stk (Bundle)
.... 21.195 Triogen, Kapseln Fachinformation
.... 21.196 Triogen, Kapseln Patienteninformation